Reporter

Diabetes, cardiovascular drug targets

Targeting receptors of the inflammatory lipid signaling molecule PGE2 may offer a new way to tackle both Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered.

Injury prevention experts highlight ABCs of water safety as summer begins

Memorial Day weekend traditionally marks the start of summer. It is also when experts see an uptick in drowning and near drowning incidents.

“Drowning is a silent killer,” said Purnima Unni, MPH, program manager, Pediatric Trauma Injury Prevention at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Vanderbilt Diabetes Day celebrates investigational achievements, looks toward future

Vanderbilt Diabetes Day, an annual event that showcases the work of outstanding scientists and researchers in the fields of diabetes, obesity and metabolism was held this month, and it marked the first time many investigators working under the auspices of the Vanderbilt Diabetes Research and Training Center (DRTC) had gathered in one space since the beginning of the COVID-19 pandemic.

VUMC to participate in AMA effort to advance equitable quality & safety in patient care

Vanderbilt University Medical Center is participating in a learning network designed to help hospital systems apply an equity lens to all aspects of quality and safety practices – with a goal of improving health outcomes for historically marginalized populations.

Pushing (anti-overdose) drugs

An automated alert to encourage clinicians to coprescribe naloxone for patients at risk of opioid overdose increased naloxone prescriptions per opioid prescription 16-fold.

Clarksville cancer center has new name

The Vanderbilt-affiliated cancer center in Clarksville has a new name: Vanderbilt-Ingram Cancer Center at Tennova Healthcare – Clarksville (VICCTHC).

1 96 97 98 99 100 770